Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Prothena Corp (NASDAQ:PRTA) in the last three months. In the table below, you’ll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Insights from analysts’ 12-month price targets are revealed, presenting an average target of $50.25, a high estimate of $84.00, and a low estimate of $24.00. A 4.74% drop is evident in the current average compared to the previous average price target of $52.75. Analyzing Anal…